BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

UNC Scientists Block Cellular Enzyme Activity Involved In Cancer Progression


10/19/2005 5:11:34 PM

The ability to switch off a cellular enzyme involved in the progression of several forms of human cancers has been discovered by researchers at the University of North Carolina School of Medicine. This enzyme is called focal adhesion kinase (FAK), which normally promotes cellular activity and growth. But overactivity of FAK encourages cancer cell growth and the spread of cancer. The UNC researchers found a segment of FAK, called the FERM domain, is crucial to the activation of FAK. They also found that subtle changes to the FERM domain suppresses FAK activity. This finding suggests it may be possible to develop drugs that mimic this modification and turn off FAK in cancer patients. The study appears in the June 2 issue of Molecular and Cellular Biology.

Read at ScienceDaily
Read at HealthDay

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->